Showing results (1301-1310 of 1,433) with videos related to

Sort By:
Pageof 144
Microbiology Spectrum|October 27, 2025
Phage Henu12-resistant mutant derives fitness trade-offs in <i>Shigella dysenteriae</i>Salwa E Gomaa, Yuhan Wang, Jingjing Li, et al.
Journal of the American Mosquito Control Association|April 23, 2016
An Unmanned Aerial Vehicle-Mounted Cold Mist Spray of Permethrin and Tetramethylfluthrin Targeting Aedes albopictus in ChinaChun-Xiao Li, Ying-Mei Zhang, Yan-De Dong, et al.
Scientific Reports|September 20, 2017
Corona discharge induced snow formation in a cloud chamberJingjing Ju, Tie-Jun Wang, Ruxin Li, et al.
International Journal of Oncology|August 28, 2012
AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cellsShih-Chang Tsai, Chi-Cheng Lu, Chao-Ying Lee, et al.
Clinical and Experimental Medicine|May 26, 2025
Predicting the risk of ibrutinib in combination with R-ICE in patients with relapsed or refractory DLBCL using explainable machine learning algorithmsNi Zhu, Rong-Bin Shen, Jun-Fa Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|June 20, 2007
[Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia]Bao-an Chen, Fan Zhang, Yan Wang, et al.
Nature Communications|May 23, 2022
The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligandsJingjing Wang, Meng Wu, Zhangcheng Chen, et al.
Journal of Medicinal Chemistry|March 23, 2022
Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer TreatmentDi Li, Yuanxiang Tu, Kaijun Jin, et al.
Acta Pharmacologica Sinica|March 16, 2022
Trilobatin rescues cognitive impairment of Alzheimer's disease by targeting HMGB1 through mediating SIRT3/SOD2 signaling pathwayJian-Mei Gao, Xun Zhang, Guo-Tao Shu, et al.
European Journal of Medicinal Chemistry|March 23, 2020
Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitorsChen Shi, Qian Wang, Xuemei Liao, et al.
Pageof 144